Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein
US6329499A · kind A · utility
4Cited by
4References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 18, 1994 |
| Grant date | Dec 11, 2001 |
| Priority date | — |
| Expiry date | Nov 18, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed toward peptide analogues of human myelin basic protein. The peptide analogue is at least seven amino acids long and derived from residues 86 to 99 of human myelin basic protein. The analogues are altered from the native sequence at least at positions 91, 95, or 97. Additional alterations may be made at other positions. Pharmaceutical compositions containing these peptide analogues are provided. The peptide analogues are useful for treating multiple sclerosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.